These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 1385521

  • 1. Neuropeptides modulate human eosinophil chemotaxis.
    Numao T, Agrawal DK.
    J Immunol; 1992 Nov 15; 149(10):3309-15. PubMed ID: 1385521
    [Abstract] [Full Text] [Related]

  • 2. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator.
    Liu L, Zuurbier AE, Mul FP, Verhoeven AJ, Lutter R, Knol EF, Roos D.
    J Immunol; 1998 Sep 15; 161(6):3064-70. PubMed ID: 9743372
    [Abstract] [Full Text] [Related]

  • 3. Leukotriene B4 mediates substance P-induced granulocyte infiltration into mouse skin. Comparison with antigen-induced granulocyte infiltration.
    Iwamoto I, Tomoe S, Tomioka H, Yoshida S.
    J Immunol; 1993 Aug 15; 151(4):2116-23. PubMed ID: 7688393
    [Abstract] [Full Text] [Related]

  • 4. Priming of eosinophil recruitment in vivo by LPS pretreatment.
    Macari DM, Teixeira MM, Hellewell PG.
    J Immunol; 1996 Aug 15; 157(4):1684-92. PubMed ID: 8759756
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils.
    Fukuda T, Numao T, Akutsu I, Makino S.
    J Lipid Mediat; 1992 Aug 15; 5(2):145-9. PubMed ID: 1525356
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Eosinophil chemotaxis induced by several biologically active substances and the effects of apafant on it in vitro.
    Nabe T, Yamamura H, Kohno S.
    Arzneimittelforschung; 1997 Oct 15; 47(10):1112-6. PubMed ID: 9368704
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of human eosinophil chemotaxis in vitro by the anti-allergic agent emedastine difumarate.
    el-Shazly AE, Masuyama K, Samejima Y, Eura M, Ishikawa T.
    Immunopharmacol Immunotoxicol; 1996 Nov 15; 18(4):587-95. PubMed ID: 8933171
    [Abstract] [Full Text] [Related]

  • 12. Effect of terfenadine on human eosinophil and neutrophil chemotactic response and generation of superoxide.
    Eda R, Townley RG, Hopp RJ.
    Ann Allergy; 1994 Aug 15; 73(2):154-60. PubMed ID: 8067599
    [Abstract] [Full Text] [Related]

  • 13. Platelet-activating factor-induced human eosinophil transendothelial migration: evidence for a dynamic role of the endothelium.
    Casale TB, Erger RA, Little MM.
    Am J Respir Cell Mol Biol; 1993 Jan 15; 8(1):77-82. PubMed ID: 8380250
    [Abstract] [Full Text] [Related]

  • 14. Immunoregulatory effect of substance P in human eosinophil migratory function.
    El-Shazly AE, Masuyama K, Eura M, Ishikawa T.
    Immunol Invest; 1996 May 15; 25(3):191-201. PubMed ID: 9157054
    [Abstract] [Full Text] [Related]

  • 15. Inhibitory effects of glucocorticoids on rat eosinophil superoxide generation and chemotaxis.
    Sugimoto Y, Ogawa M, Tai N, Kamei C.
    Int Immunopharmacol; 2003 Jun 15; 3(6):845-52. PubMed ID: 12781701
    [Abstract] [Full Text] [Related]

  • 16. Leukotriene C4 production from human eosinophils in vitro. Role of eosinophil chemotactic factors on eosinophil activation.
    Tamura N, Agrawal DK, Townley RG.
    J Immunol; 1988 Dec 15; 141(12):4291-7. PubMed ID: 2848892
    [Abstract] [Full Text] [Related]

  • 17. Tumor necrosis factor alpha induces migration of human eosinophils.
    Nagata M, Fukuda T, Numao T, Makino S, Dohi Y.
    Arerugi; 1993 Apr 15; 42(4):549-55. PubMed ID: 8323453
    [Abstract] [Full Text] [Related]

  • 18. Enhancement of the expression of eosinophil IgE receptor (Fc epsilon R2) and its function by platelet-activating factor.
    Walsh GM, Moqbel R, Nagakura T, Iikura Y, Kay AB.
    J Lipid Mediat; 1990 Apr 15; 2 Suppl():S177-86. PubMed ID: 1966815
    [Abstract] [Full Text] [Related]

  • 19. Comparative studies indicate that platelet-activating factor is a relatively weak eosinophilotactic mediator.
    Erger RA, Casale TB.
    Am J Respir Cell Mol Biol; 1995 Jan 15; 12(1):65-70. PubMed ID: 7811471
    [Abstract] [Full Text] [Related]

  • 20. RANTES is a chemotactic and activating factor for human eosinophils.
    Alam R, Stafford S, Forsythe P, Harrison R, Faubion D, Lett-Brown MA, Grant JA.
    J Immunol; 1993 Apr 15; 150(8 Pt 1):3442-8. PubMed ID: 7682241
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.